Envoy Medical Inc Ordinary Shares - Class A COCH

Morningstar Rating
$6.60 −0.07 (1.05%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

COCH is trading at a LOCK|q@BZ@ premium.
Price
$6.60
Fair Value
LOCK|&$%$j?
Uncertainty
LOCK|@< bFQPX
1-Star Price
LOCK|.#d?LqP>
5-Star Price
LOCK|@&$@%n
Economic Moat
LOCK|mM%K
Capital Allocation
—

News

Trading Information

Previous Close Price
$6.65
Day Range
$6.60–6.60
52-Week Range
$3.80–9.50
Bid/Ask
$4.65 / $8.66
Shares Outstanding
7.74M
Market Cap
$51.24M
Volume/Avg
11,159 / 12,393

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
178.69
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
47

Valuation

Metric
COCH
Price/Earnings (Normalized)
—
Price/Book Value
15.47
Price/Sales
178.69
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
COCH
Quick Ratio
1.56
Current Ratio
1.73
Interest Coverage
−48.68
Quick Ratio
COCH

Profitability

Metric
COCH
Return on Assets (Normalized)
−142.79%
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
COCH

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|YGF?x#>LOCK|wHh@$189B
Medtronic PLC
MDT
LOCK|^^dB>#sLOCK|^!Vvc$126B
Stryker Corp
SYK
LOCK|j#T?Wq^pLOCK|?>@$118B
Boston Scientific Corp
BSX
LOCK|<Sm!#jLOCK|BfYH$63B
Edwards Lifesciences Corp
EW
LOCK|><%?%#nLOCK|#^ZTQ$55B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|$Gh<>ylLOCK|sp<$36B
DexCom Inc
DXCM
LOCK|$@@L%FpqLOCK|<Y?%@$31B
Koninklijke Philips NV ADR
PHG
LOCK|jfLOCK|cR$28B
Steris PLC
STE
LOCK|hrZ^@dLOCK|#&?w$23B
Zimmer Biomet Holdings Inc
ZBH
LOCK|Q!#jLbmLOCK|$yS$19B

Sponsor Center